Dietary Inflammatory Index and Risk of Colorectal Adenoma Recurrence: A Pooled Analysis

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015. doi: 10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dores GM, and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24, 2137–2150, 2006. doi: 10.1200/jco.2005.05.2308
   PubMed Web of Science ®Google Scholar
• Janout V and Kollarova H: Epidemiology of colorectal cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 145, 5–10, 2001.
   PubMedGoogle Scholar
• Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, et al.: Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81, 341–354, 2005.
   PubMed Web of Science ®Google Scholar
• Sunkara V and Hebert JR: The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer 121, 1563–1569, 2015. doi: 10.1002/cncr.29228
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, Hussey JR, and Hebert JR: Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr 17, 1689–1696, 2014. doi: 10.1017/s1368980013002115
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, Hussey JR, Ma Y, et al.: A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). Public Health Nutr 17, 1825–1833, 2014. doi: 10.1017/s1368980013002565
   PubMed Web of Science ®Google Scholar
• Shivappa N, Hebert JR, Rietzschel ER, De Buyzere ML, Langlois M, et al.: Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study. Br J Nutr 113, 665–671, 2015. doi: 10.1017/S000711451400395X
   PubMed Web of Science ®Google Scholar
• Wirth MD, Burch J, Shivappa N, Violanti JM, Burchfiel CM, et al.: Association of a dietary inflammatory index with inflammatory indices and metabolic syndrome among police officers. J Occup Environ Med 56, 986–989, 2014. doi: 10.1097/JOM.0000000000000213
   PubMed Web of Science ®Google Scholar
• Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, et al.: Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol 25, 398–405, 2015. doi: 10.1016/j.annepidem.2015.03.009
   PubMed Web of Science ®Google Scholar
• Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, et al.: The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women's Health Initiative. Cancer Causes Control 26, 399–408, 2015. doi: 10.1007/s10552-014-0515-y
   PubMed Web of Science ®Google Scholar
• Shivappa N, Zucchetto A, Montella M, Serraino D, Steck SE, et al.: Inflammatory potential of diet and risk of colorectal cancer: a case-control study from Italy. Br J Nutr 114, 152–158, 2015. doi: 10.1017/s0007114515001828
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Shivappa N, Steck SE, Canzian F, Landi S, et al.: Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case-control study. Genes Nutr 10, 447, 2015. doi: 10.1007/s12263-014-0447-x
   PubMed Web of Science ®Google Scholar
• Shivappa N, Prizment AE, Blair CK, Jacobs DR, Jr., Steck SE, et al.: Dietary inflammatory index and risk of colorectal cancer in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 23, 2383–2392, 2014. doi: 10.1158/1055-9965.epi-14-0537
   PubMed Web of Science ®Google Scholar
• Wirth MD, Shivappa N, Steck SE, Hurley TG, and Hebert JR: The dietary inflammatory index is associated with colorectal cancer in the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Br J Nutr 113, 1819–1827, 2015. doi: 10.1017/s000711451500104x
   PubMed Web of Science ®Google Scholar
• Shivappa N, Blair CK, Prizment AE, Jacobs DR, Jr., Steck SE, et al.: Association between inflammatory potential of diet and mortality in the Iowa Women's Health study. Eur J Nutr 55, 1491–1502, 2015. doi: 10.1007/s00394-015-0967-1
   PubMed Web of Science ®Google Scholar
• Hill M, Morson B, and Bussey H: Aetiology of adenoma‚Äîcarcinoma sequence in large bowel. Lancet 311, 245–247, 1978.
   Web of Science ®Google Scholar
• Levine JS and Ahnen DJ: Adenomatous polyps of the colon. New Engl J Med 355, 2551–2557, 2006.
   PubMed Web of Science ®Google Scholar
• Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, et al.: Risk factors for advanced colorectal adenomas a pooled analysis. Cancer Epidemiol Biomarkers Prev 11, 622–629, 2002.
   PubMed Web of Science ®Google Scholar
• Neugut AI, Jacobson JS, Ahsan H, Santos J, Garbowski GC, et al.: Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology 108, 402–408, 1995.
   PubMed Web of Science ®Google Scholar
• Hursting SD, Slaga TJ, Fischer SM, DiGiovanni J, and Phang JM: Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst 91, 215–225, 1999.
   PubMedGoogle Scholar
• Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, et al.: Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120, 1077–1183, 2001. doi: 10.1053/gast.2001.0050101083
   PubMed Web of Science ®Google Scholar
• Almendingen K, Hofstad B, and Vatn M: Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas? Gut 52, 747, 2003.
   PubMed Web of Science ®Google Scholar
• Logan RF, Grainge MJ, Shepherd VC, Armitage NC, and Muir KR: Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134, 29–38, 2008. doi: 10.1053/j.gastro.2007.10.014
   PubMed Web of Science ®Google Scholar
• Almendingen K, Hofstad B, and Vatn MH: Dietary habits and growth and recurrence of colorectal adenomas: results from a three-year endoscopic follow-up study. Nutr Cancer 49, 131–138, 2004.
   PubMed Web of Science ®Google Scholar
• Hibler EA, Molmenti CL, Lance P, Jurutka PW, and Jacobs ET: Associations between circulating 1,25(OH)(2)D concentration and odds of metachronous colorectal adenoma. Cancer Causes Control 25, 809–817, 2014. doi: 10.1007/s10552-014-0382-6
   PubMed Web of Science ®Google Scholar
• Hibler EA, Jacobs ET, Stone AD, Sardo CL, Galligan MA, et al.: Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells. Cancer Prev Res (Phila) 7, 426–434, 2014. doi: 10.1158/1940-6207.capr-13-0269
   PubMed Web of Science ®Google Scholar
• Hibler EA, Klimentidis YC, Jurutka PW, Kohler LN, Lance P, et al.: CYP24A1 and CYP27B1 polymorphisms, concentrations of vitamin d metabolites, and odds of colorectal adenoma recurrence. Nutr Cancer 67, 1131–1141, 2015. doi: 10.1080/01635581.2015.1068818
   PubMed Web of Science ®Google Scholar
• Terzic J, Grivennikov S, Karin E, and Karin M: Inflammation and colon cancer. Gastroenterology 138, 2101–2114. e5, 2010.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M: IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 26, 54–74, 2014. doi: 10.1016/j.smim.2014.01.001
   PubMed Web of Science ®Google Scholar
• Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, et al.: Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 132, 2648–2658, 2013. doi: 10.1002/ijc.27942
   PubMed Web of Science ®Google Scholar
• Wu J, Cai Q, Li H, Cai H, Gao J, et al.: Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study. Carcinogenesis 34, 2799–2803, 2013. doi: 10.1093/carcin/bgt288
   PubMed Web of Science ®Google Scholar
• Erlinger TP, Platz EA, Rifai N, and Helzlsouer KJ: C-reactive protein and the risk of incident colorectal cancer. JAMA 291, 585–590, 2004.
   PubMed Web of Science ®Google Scholar
• Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, et al.: A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66, 2483, 2006.
   PubMed Web of Science ®Google Scholar
• Aleksandrova K, Jenab M, Boeing H, Jansen E, Bueno-de-Mesquita HB, et al.: Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol 172, 407–418, 2010. doi: 10.1093/aje/kwq135
   PubMed Web of Science ®Google Scholar
• Lee S, Choe JW, Kim HK, and Sung J: High-sensitivity C-reactive protein and cancer. J Epidemiol 21, 161–168, 2011.
   PubMed Web of Science ®Google Scholar
• Prizment AE, Anderson KE, Visvanathan K, and Folsom AR: Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev 20, 297–307, 2011. doi: 10.1158/1055-9965.epi-10-1146
   PubMed Web of Science ®Google Scholar
• Zhou B, Shu B, Yang J, Liu J, Xi T, et al.: C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control 25, 1397–1405, 2014. doi: 10.1007/s10552-014-0445-8
   PubMed Web of Science ®Google Scholar
• Heikkila K, Harris R, Lowe G, Rumley A, Yarnell J, et al.: Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20, 15–26, 2009. doi: 10.1007/s10552-008-9212-z
   PubMed Web of Science ®Google Scholar
• Chan AT, Ogino S, Giovannucci EL, and Fuchs CS: Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology 140, 799–808, quiz e11, 2011. doi: 10.1053/j.gastro.2010.11.041
   PubMed Web of Science ®Google Scholar
• Song M, Wu K, Ogino S, Fuchs CS, Giovannucci EL, et al.: A prospective study of plasma inflammatory markers and risk of colorectal cancer in men. Br J Cancer 108, 1891–1898, 2013. doi: 10.1038/bjc.2013.172
   PubMed Web of Science ®Google Scholar
• Ho GY, Wang T, Zheng SL, Tinker L, Xu J, et al.: Circulating soluble cytokine receptors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 23, 179–188, 2014. doi: 10.1158/1055-9965.epi-13-0545
   PubMed Web of Science ®Google Scholar
• Song M, Mehta RS, Wu K, Fuchs CS, Ogino S, et al.: Plasma inflammatory markers and risk of advanced colorectal adenoma in women. Cancer Prev Res (Phila) 9, 27–34, 2015. doi: 10.1158/1940-6207.capr-15-0307
   PubMed Web of Science ®Google Scholar
• Bobe G, Murphy G, Albert PS, Sansbury LB, Young MR, et al.: Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols? Eur J Cancer Prev 20, 86–95, 2011. doi: 10.1097/CEJ.0b013e3283429e45
   PubMed Web of Science ®Google Scholar
• Bobe G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, et al.: Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev Res (Phila) 3, 764–775, 2010. doi: 10.1158/1940-6207.capr-09-0161
   PubMed Web of Science ®Google Scholar
• Henry CJ, Sedjo RL, Rozhok A, Salstrom J, Ahnen D, et al.: Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma. BMC Cancer 15, 123, 2015. doi: 10.1186/s12885-015-1115-2
   PubMed Web of Science ®Google Scholar
• Crockett SD, Mott LA, Barry EL, Figueiredo JC, Burke CA, et al.: C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study. Cancer Prev Res (Phila) 7, 1122–1127, 2014. doi: 10.1158/1940-6207.capr-14-0167
   PubMed Web of Science ®Google Scholar
• Tsilidis KK, Erlinger TP, Rifai N, Hoffman S, Hoffman-Bolton J, et al.: C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer Causes and Control 19, 559–567, 2008.
   PubMed Web of Science ®Google Scholar
• Bobe G, Murphy G, Albert PS, Sansbury LB, Lanza E, et al.: Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial. Br J Cancer 103, 1453–1461, 2010. doi: 10.1038/sj.bjc.6605915
   PubMed Web of Science ®Google Scholar
• Chan AT, Sima CS, Zauber AG, Ridker PM, Hawk ET, et al.: C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res (Phila) 4, 1172–1180, 2011. doi: 10.1158/1940-6207.capr-10-0403
   PubMed Web of Science ®Google Scholar
• Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, et al.: Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst 101, 1650–1654, 2009. doi: 10.1093/jnci/djp346
   PubMedGoogle Scholar
• Brown DA, Hance KW, Rogers CJ, Sansbury LB, Albert PS, et al.: Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? Cancer Epidemiol Biomarkers Prev 21, 337–346, 2012. doi: 10.1158/1055-9965.epi-11-0786
   PubMed Web of Science ®Google Scholar
• Flossmann E and Rothwell PM: Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369, 1603–1613, 2007. doi: 10.1016/s0140-6736(07)60747-8
   PubMed Web of Science ®Google Scholar
• Friis S, Poulsen AH, Sorensen HT, Tjonneland A, Overvad K, et al.: Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study. Cancer Causes Control 20, 731–740, 2009. doi: 10.1007/s10552-008-9286-7
   PubMed Web of Science ®Google Scholar
• Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, et al.: Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 134, 21–28, 2008. doi: 10.1053/j.gastro.2007.09.035
   PubMed Web of Science ®Google Scholar
• Larsson SC, Giovannucci E, and Wolk A: Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer 95, 1277–1279, 2006. doi: 10.1038/sj.bjc.6603442
   PubMed Web of Science ®Google Scholar
• Chubak J, Kamineni A, Buist DSM, Anderson ML, Whitlock EP: U.S. preventive services task force evidence syntheses, formerly systematic evidence reviews. In: Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the US Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US), 2015.
   Google Scholar
• Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, et al.: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348, 883–890, 2003. doi: 10.1056/NEJMoa021633
   PubMed Web of Science ®Google Scholar
• Baron JA, Sandler RS, Bresalier RS, Quan H, Riddell R, et al.: A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131, 1674–1682, 2006. doi: 10.1053/j.gastro.2006.08.079
   PubMed Web of Science ®Google Scholar
• Benamouzig R, Uzzan B, Martin A, Deyra J, Little J, et al.: Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention. Gut 59, 622–629, 2010. doi: 10.1136/gut.2008.175406
   PubMed Web of Science ®Google Scholar
• Akhter M, Iwasaki M, Yamaji T, Sasazuki S, and Tsugane S: Dietary isoflavone and the risk of colorectal adenoma: a case-control study in Japan. Br J Cancer 100, 1812–1816, 2009. doi: 10.1038/sj.bjc.6605088
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund / American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007.
   Google Scholar
• Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, et al.: Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 17, 1344–1353, 2008. doi: 10.1158/1055-9965.epi-07-0747
   PubMed Web of Science ®Google Scholar
• Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, et al.: Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 342, 1156–1162, 2000. doi: 10.1056/nejm200004203421602
   PubMed Web of Science ®Google Scholar
• Kunzmann AT, Coleman HG, Huang WY, Kitahara CM, Cantwell MM, et al.: Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 102, 881–890, 2015. doi: 10.3945/ajcn.115.113282
   PubMed Web of Science ®Google Scholar
• Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, et al.: A trial of calcium and vitamin D for the prevention of colorectal adenomas. N Engl J Med 373, 1519–1530, 2015. doi: 10.1056/NEJMoa1500409
   PubMed Web of Science ®Google Scholar
• Miller PE, Lesko SM, Muscat JE, Lazarus P, and Hartman TJ: Dietary patterns and colorectal adenoma and cancer risk: a review of the epidemiological evidence. Nutr Cancer 62, 413–424, 2010.
   PubMed Web of Science ®Google Scholar
• Alberts DS, Martinez ME, Hess LM, Einspahr JG, Green SB, et al.: Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97, 846–853, 2005. doi: 10.1093/jnci/dji144
   PubMed Web of Science ®Google Scholar
• Ritenbaugh C, Aickin M, Taren D, Teufel N, Graver E, et al.: Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trial. Cancer Epidemiol Biomarkers Prev 6, 347–354, 1997.
   PubMed Web of Science ®Google Scholar
• Earnest DL, Sampliner RE, Roe DJ, van Leeuwen B, Guillen J, et al.: Progress report: the Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps. Am J Med 106, 43S–45S, 1999.
   PubMedGoogle Scholar
• Martinez ME, Marshall JR, Graver E, Whitacre RC, Woolf K, et al.: Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev 8, 941–946, 1999.
   PubMed Web of Science ®Google Scholar
• Staten LK, Taren DL, Howell WH, Tobar M, Poehlman ET, et al.: Validation of the Arizona activity frequency questionnaire using doubly labeled water. Med Sci Sports Exerc 33, 1959, 2001.
   PubMed Web of Science ®Google Scholar
• Neuhouser ML, Di C, Tinker LF, Thomson C, Sternfeld B, et al.: Physical activity assessment: biomarkers and self-report of activity-related energy expenditure in the WHI. Am J Epidemiol 177, 576–585, 2013.
   PubMed Web of Science ®Google Scholar
• Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, et al.: 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43, 1575–1581, 2011.
   PubMed Web of Science ®Google Scholar
• Sedentary Behaviour Research N: Letter to the editor: standardized use of the terms “sedentary” and “sedentary behaviours”. Appl Physiol Nutr Metab 37, 540–542, 2012. doi: 10.1139/h2012-024
   PubMed Web of Science ®Google Scholar
• Mickey RM and Greenland S: The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129, 125, 1989.
   PubMed Web of Science ®Google Scholar
• WHO: Global Database on Body Mass Index; http://apps.who.int/bmi/index.jsp?introPage=intro_3.html; accessed 8/26/2013.
   Google Scholar
• Molmenti CL, Hibler EA, Ashbeck EL, Thomson CA, Garcia DO, et al.: Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control 25, 1387–1395, 2014. doi: 10.1007/s10552-014-0444-9
   PubMed Web of Science ®Google Scholar
• Thompson PA, Wertheim BC, Roe DJ, Ashbeck EL, Jacobs ET, et al.: Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prev Res (Phila) 2, 1023–1030, 2009. doi: 10.1158/1940-6207.capr-09-0234
   PubMed Web of Science ®Google Scholar
• Martinez ME, Jacobs ET, Ashbeck EL, Sinha R, Lance P, et al.: Meat intake, preparation methods, mutagens and colorectal adenoma recurrence. Carcinogenesis 28, 2019–2027, 2007. doi: 10.1093/carcin/bgm179
   PubMed Web of Science ®Google Scholar
• Gunter MJ, Cross AJ, Huang WY, Stanczyk FZ, Purdue M, et al.: A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev 20, 537–544, 2011. doi: 10.1158/1055-9965.epi-10-1099
   PubMed Web of Science ®Google Scholar
• Szylberg L, Janiczek M, Popiel A, and Marszalek A: Large Bowel Genetic Background and Inflammatory Processes in Carcinogenesis – Systematic Review. Adv Clin Exp Med 24, 555–563, 2015. doi: 10.17219/acem/31239
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z: Inflammation and cancer. Nature 420, 860–867, 2002.
   PubMed Web of Science ®Google Scholar